| Literature DB >> 29513702 |
Julia Wijkström1, Channa Jayasumana2, Rajeewa Dassanayake3, Nalin Priyawardane3, Nimali Godakanda3, Sisira Siribaddana4, Anneli Ring5, Kjell Hultenby6, Magnus Söderberg5,7, Carl-Gustaf Elinder1, Annika Wernerson1.
Abstract
In Sri Lanka, an endemic of chronic kidney disease of unknown origin (CKDu) is affecting rural communities. The endemic has similarities with Mesoamerican Nephropathy (MeN) in Central America, however it has not yet been clarified if the endemics are related diagnostic entities. We designed this study of kidney biopsies from patients with CKDu in Sri Lanka to compare with MeN morphology. Eleven patients with CKDu were recruited at the General Hospital, Polonnaruwa, using similar inclusion and exclusion criteria as our previous MeN studies. Inclusion criteria were 20-65 years of age and plasma creatinine 100-220 μmol/L. Exclusion criteria were diabetes mellitus, uncontrolled hypertension and albuminuria >1g/24h. Kidney biopsies, blood and urine samples were collected, and participants answered a questionnaire. Included participants were between 27-61 years of age and had a mean eGFR of 38±14 ml/min/1.73m2. Main findings in the biopsies were chronic glomerular and tubulointerstitial damage with glomerulosclerosis (8-75%), glomerular hypertrophy and mild to moderate tubulointerstitial changes. The morphology was more heterogeneous and interstitial inflammation and vascular changes were more common compared to our previous studies of MeN. In two patients the biopsies showed morphological signs of acute pyelonephritis but urine cultures were negative. Electrolyte disturbances with low levels of serum sodium, potassium, and/or magnesium were common. In the urine, only four patients displayed albuminuria, but many patients exhibited elevated α-1-microglobulin and magnesium levels. This is the first study reporting detailed biochemical and clinical data together with renal morphology, including electron microscopy, from Sri Lankan patients with CKDu. Our data show that there are many similarities in the biochemical and morphological profile of the CKDu endemics in Central America and Sri Lanka, supporting a common etiology. However, there are differences, such as a more mixed morphology, more interstitial inflammation and vascular changes in Sri Lankan patients.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29513702 PMCID: PMC5841753 DOI: 10.1371/journal.pone.0193056
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patient characteristics and questionnaire results of working history, n = 11.
| 48 ± 11 (27–61) | |
| 56.6 ± 8.8 (46.9–77.0) | |
| 1.66 ± 0.07 | |
| 20 ± 3 (16–28) | |
| 122 ± 20 (97–160) | |
| 78 ± 9 (58–90) | |
| 8.7 ± 0.6 (7.8–9.8) | |
| 3 (27%) | |
| 0 (0%) | |
| 1 (9%) | |
| Farmer | 7 (64%) |
| Farmer and construction worker | 1 (9%) |
| Farmer, agricultural worker and rice mill laborer | 1 (9%) |
| Farmer and pesticide sprayer | 1 (9%) |
| Security officer | 1 (9%) |
| 24 ± 13 (3–40) | |
| 37 ± 19 (20–80) | |
| 807 ± 573 (174–2000) | |
| 11 ± 12 (0–30) | |
| 1.6 ± 1.9 (0–6.2) | |
| 4.3 ± 0.9 (3.0–6.0) | |
| Own well | 6 (55%) |
| Village well | 2 (18%) |
| Tube well | 2 (18%) |
| Main supply | 1 (9%) |
Note: Results are presented as mean ± SD (range) or cases (percentage).
a Two patients had increased systolic blood pressure at the morning of the biopsy (145/90 and 160/80 respectively), but were normal the day before the biopsy (130/90 and 130/80 respectively).
Questionnaire results of chronic diseases and medicine use.
| Study no | Chronic diseases | Drug 1 | Drug 2 | Drug 3 | Drug 4 | Drug 5 | Drug 6 | Drug 7 |
|---|---|---|---|---|---|---|---|---|
| 1 | Pain in legs | KCl | CaCO3 | Gabapentin | Fluoxetin | Amitriptyline | ||
| 2 | Knee pain | - | ||||||
| 3 | Asthma | Alfacalcidol | Omeprazol | Famotidine 20 mg, 2/d. | Domperidone | Gabapentin | Salbutamol | Beclamethasone |
| 4 | Hypertension | Losartan | CaCO3 | FeSO4 | ||||
| 5 | - | Losartan | CaCO3 | |||||
| 6 | - | - | ||||||
| 7 | Joint pain | CaCO3 | ||||||
| 8 | Insomnia | Alfacalcidol | CaCO3 | FeSO4 | Amitriptyline | |||
| 9 | - | CaCO3 | ||||||
| 10 | - | - | ||||||
| 11 | Hemorrhoids | Spironolactone | KCl | CaCO3 | Alfacalcidol |
Note: Abbreviations: KCl, Potassium chloride. CaCO3, Calcium carbonate. FeSO4, Iron (II) sulfate. Inh, inhalation.
Serum test results, n = 11.
| Serum variable | Mean ± SD (range) |
|---|---|
| Creatinine (μmol/L) | 184 ± 50 (120–267) |
| Cystatin C (mg/L) | 1.96 ± 0.53 (1.18–2.90) |
| eGFRCr (ml/min/1.73m2) | 40 ± 14 (21–70) |
| eGFRCr+Cyst C (ml/min/1.73m2) | 38 ± 14 (20–66) |
| Sodium (mmol/L) | 140 ± 4 (134–147) |
| Potassium (mmol/L) | 4.3 ± 1.0 (2.2–6.3) |
| Magnesium (mmol/L) | 0.70 ± 0.16 (0.43–0.88) |
| Uric Acid (μmol/L) | 420 ± 97 (201–583) |
| Calcium (mmol/L) | 2.25 ± 0.40 (1.12–2.56) |
| Albumin (g/L) | 38 ± 7 (18–45) |
| Phosphate (mmol/L) | 1.0 ± 0.2 (0.59–1.4) |
| Glucose (mmol/L) | 5.2 ± 1.1 (2.9–6.8) |
| Hemoglobin (g/L) | 124 ± 19 (100–156) |
| White blood cell count (109/L) | 7.35 ± 1.35 (4.91–10.25) |
| Aldosterone (nmol/L) | 0.36 ± 0.27 (0.09–0.95) |
| Renin (mIU/L) | 28 ± 26 (3–90) |
| Dobra-Hantaan virus IgM | All negative |
| Hantaan virus IgG | 8 positive, 3 negative |
| Puumala virus IgM | All negative |
| Puumala virus IgG | All negative |
Note:
a Low sodium (<137 mmol/L) in one patient.
b Low potassium (<3.5mmol/L) in two patients (2.2 and 3.4 mmol/L).
c Low magnesium (<0.7 mmol/L) in four patients (0.43, 0.44, 0.61, and 0.64 mmol/L).
d High uric acid (>416 μmol/L) in six patients.
e Low calcium in two patients (1.12 and 2.07 mmol/L) and high calcium in two patients (2.55 and 2.56 mmol/L). The patient with calcium 1.12 mmol/L had serum albumin 18 g/L.
f High aldosterone (>0.65 nmol/L) in two patients (0.77 and 0.95 nmol/L).
g High renin (>40 mIU/L) in two patients (50 and 90 mIU/L).
Urine test results including urine heavy metals, n = 11.
| Urine variable | Mean ± SD (range) |
|---|---|
| Culture | All negative |
| Creatinine (mmol/L) | 8.4 ± 4.5 (2.4–17.2) |
| ACR (mg/mmol) | 7.2 ± 14.1 (0.1–47.2) |
| A1M-creatinine ratio (mg/mmol) | 5.2 ± 4.1 (0.8–14.5) |
| NGAL (μg/L) | 47 ± 52 (17.5–154) |
| KIM-1 (ng/ml) | 1.1 ± 0.98 (0.19–3.44) |
| Sodium (mmol/L) | 104 ± 71 (36–299) |
| FENa (%) | 1.8 ± 0.8 (0.5–3.3) |
| Potassium (mmol/L) | 27 ± 14 (5–50) |
| Potassium-creatinine ratio | 3.3 ± 0.9 (1.9–5.3) |
| FEK (%) | 15 ± 6 (8–25) |
| Magnesium (mmol/L) | 2.1 ± 0.9 (1.1–3.7) |
| FEMg (%) | 11 ± 5 (4–17) |
| Uric acid (mmol/L) | 1.3 ± 0.6 (0.5–2.6) |
| Uric acid-creatinine ratio | 0.17 ± 0.03 (0.12–0.23) |
| Arsenic (μg/L) | 37 ± 21 (4.5–77) |
| Arsenic-creatinine ratio (μg/g) | 42 ± 23 (17–98) |
| Cadmium (μg/L) | 0.42 ± 0.30 (0.11–1.10) |
| Cadmium-creatinine ratio (μg/g) | 0.49 ± 0.27 (0.2–1.05) |
| Mercury (μg/L) | 0.24 ± 0.18 (<0.2–0.69) |
| Mercury-creatinine ratio (μg/g) | 0.3 ± 0.22 (0.08–0.79) |
| Lead (μg/L) | 0.6 ± 0.5 (<0.5–1.72) |
| Uranium (μg/L) | <0.02 μg/L in all patients |
| Vanadium (μg/L) | 0.08 ± 0.06 (<0.1–0.22) |
Note: Abbreviations: ACR, albumin-creatinine ratio. A1M, alpha-1-microglobulin. NGAL, neutrophil gelatinase-associated lipocalin. KIM-1, kidney injury molecule-1. FENa, fractional excretion of sodium. FEK, fractional excretion of potassium. FEMg, fractional excretion of magnesium.
When calculating means, values below measurable levels were converted to half of the lowest measurable value: albumin <3.0 mg/L was converted to 1.5 mg/L; A1M <6 mg/L to 3 mg/L; NGAL <35 μg/L to 17.5 μg/L; mercury <0.2 μg/L to 0.1 μg/L; lead 0.5 μg/L to 0.25 μg/L; and vanadium <0.1 μg/L to 0.05 μg/L.
a ACR was >3.4 mg/mmol in four patients at 4.9, 11.3, 13.2 and 47.3 mg/mmol.
b A1M was > 0.7 mg/mmol in 10 patients. In one patient A1M was below measurable levels (<6 mg/L).
c NGAL was >50 μg/L in three patients at 111, 115, and 154 μg/L.
d Five patients had mercury below measurable levels, i.e. <0.2 μg/L.
e Four patients had lead below measurable levels, i.e. <0.5 μg/L.
f Eight patients had vanadium below measurable levels, i.e. <0.1 μg/L.
Summary of renal morphology findings by light and electron microscopy.
| 17 ± 6 (7–29) | ||
| Mean % globally sclerosed glomeruli | 43 ± 20 (8–75) % | |
| % globally sclerosed glomeruli | ||
| <25% | 2 | 18% |
| 25–50% | 4 | 36% |
| >50% | 5 | 45% |
| Segmental scleroses | 0 | 0% |
| Glomerular hypertrophy | ||
| 0 | 0 | 0% |
| 1 | 6 | 55% |
| 2 | 4 | 36% |
| 3 | 1 | 9% |
| Wrinkled GBM / Periglomerular fibrosis | ||
| Yes | 7 | 64% |
| No | 4 | 36% |
| Tubular atrophy | ||
| 0 | 0 | 0% |
| 1 | 10 | 91% |
| 2 | 1 | 9% |
| 3 | 0 | 0% |
| Interstitial fibrosis | ||
| 0 | 0 | 0% |
| 1F | 6 | 55% |
| 2F | 4 | 36% |
| 3F | 1 | 9% |
| Interstitial inflammation | ||
| 0 | 2 | 18% |
| 1 | 5 | 45% |
| 2 | 2 | 18% |
| 3 | 2 | 18% |
| Intimal thickening, n = 10 | ||
| 0 | 5 | 50% |
| 1 | 2 | 20% |
| 2 | 3 | 30% |
| 3 | 0 | 0% |
| Smooth muscle hyperplasia, n = 10 | ||
| 0 | 6 | 60% |
| 1 | 4 | 40% |
| 2 | 0 | 0% |
| 3 | 0 | 0% |
| Arteriolar hyalinosis, n = 11 | ||
| 0 | 1 | 9% |
| 1 | 7 | 64% |
| 2 | 3 | 27% |
| 3 | 0 | 0% |
| 307 ± 39 (259–349) | ||
| 1.5 ± 0.2 (1.2–1.8) | ||
| No (normal) | 11 | 100% |
| Segmental effacement | 2 | 18% |
| Widespread effacement | 0 | 0% |
| Normal | 11 | 100% |
| Swollen | 0 | 0% |
| Yes | 9 | 82% |
| No | 2 | 18% |
| Yes | 0 | 0% |
| No | 11 | 100% |
Results are presented as mean ± SD (range) or cases and percentage.
Abbreviations: GBM, glomerular basement membrane.
Fig 1Light microscopy images of glomerular pathology in Sri Lankan patients with CKDu.
Global glomerulosclerosis (stars in A and D) and glomerular hypertrophy (black arrow heads in B and D) of varying degree were found in all biopsies. Signs of glomerular ischemia with thickening of Bowman’s capsule (white arrow heads in C and D) and/or wrinkling of the capillaries was seen in seven patients. [Fig A: hematoxylin-eosin from Patient 4, bar = 200μm. Fig B: periodic acid Schiff from Patient 6, bar = 50μm. Fig C: periodic acid silver methenamine from Patient 3, bar = 50μm. Fig D: periodic acid silver methenamine from Patient 6, bar = 100μm.].
Fig 2Light microscopy images of vascular pathology in Sri Lankan patients with CKDu.
Most of the biopsies showed no or mild intimal fibrosis in arteries (arrow head in A). Three patients showed moderate intimal fibrosis (B). [Fig A: hematoxylin-eosin from Patient 6, bar = 100μm. Fig B: hematoxylin-eosin from Patient 3, bar = 100μm.].
Fig 3Light microscopy images of tubulointerstitial pathology in patients with CKDu in Sri Lanka.
Mild to moderate interstitial fibrosis was found in most patients (black arrow heads in A). Tubular atrophy was mostly mild (black arrows in B). Interstitial inflammation was of varying degree ranging from none to severe (B, A, D and C). Signs of pyelonephritis with interstitial inflammation and neutrophil granulocytes in tubules were found in two patients (white arrow heads in D). [Fig A: Ladewig from Patient 7, bar = 200μm. Fig B: periodic acid Schiff from Patient 4, bar = 100μm. Fig C: hematoxylin-eosin from Patient 3, bar = 100μm. Fig D: hematoxylin-eosin from Patient 11, bar = 100μm.].
Fig 4Transmission electron microscopy findings.
Segmental podocytic foot process effacement was observed in two patients (A, Patient 4). Podocytic cytoplasm inclusions of vacuoles or lipofuscin-like-bodies (arrows in B, Patient 6) were found in the majority of the patients. c = capillary, pc = podocyte. Bars = (A) 2μm, (B) 5 μm.